SCHEMBL3845928

SCHEMBL3845928

COc1ccc(-c2ccc(-c3ccn(C(c4ccccc4)(c4ccccc4)c4ccccc4)n3)cc2)cn1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 7/20 0.46
HSD17B1 P14061 1/20 0.42
HSD17B2 P37059 1/20 0.42
JAK2 O60674 1/20 0.41
TEK Q02763 4/20 0.41
EPHB4 P54760 3/20 0.40
MKNK1 Q9BUB5 1/20 0.40
MKNK2 Q9HBH9 1/20 0.40
CYP2A6 P11509 1/20 0.39
GRM5 P41594 1/20 0.38
RIOK2 Q9BVS4 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
ACP1 P24666 1/20 0.37
OXTR P30559 1/20 0.37
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
PDGFRB P09619 1/20 0.36
PDGFRA P16234 1/20 0.36
NPC1 O15118 1/20 0.36
LMNA P02545 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3852029 0.95 KDR (0.43) KDRHSD17B1HSD17B2JAK2EPHB4
SCHEMBL3846623 0.79 KMT2A (0.34) KDRJAK2KMT2ANPC1
SCHEMBL5800759 0.78 KMT2A (0.52) L3MBTL1MEN1KMT2ANPC1
SCHEMBL3849059 0.77 KDR (0.42) KDRHSD17B1HSD17B2JAK2TEK
SCHEMBL3846751 0.77 KMT2A (0.44) L3MBTL1MEN1KMT2ANPC1LMNA
SCHEMBL3853768 0.75 HSD17B1 (0.41) KDRHSD17B1HSD17B2JAK2TEK
SCHEMBL3850285 0.75 ALDH1A1 (0.49) L3MBTL1MEN1KMT2ANPC1PKM
SCHEMBL1422182 0.74 HSD17B1 (0.67) KDRHSD17B1HSD17B2MKNK1MKNK2
SCHEMBL3846335 0.74 KDR (0.38) KDRHSD17B1HSD17B2JAK2TEK
SCHEMBL3845757 0.74 MAPT (0.42) MEN1KMT2ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed